Autori: Prat A
| Naslov | HER-Seq: A blood-based genomic screening study to identify HER2 mutation-positive patients for enrollment into clinical trials with the pan-HER inhibitor neratinib (Meeting Abstract) |
| Autori | Tomasevic Zoran M Smyth LM Saura C Boni V Garcia-Saenz JA Prat A Eli L Garza SJ Lalani AS Crown JP |
| Info | ANNALS OF ONCOLOGY, (2019), vol. 30 br. , Suppl. 3, str. - |
| Projekat | Puma Biotechnology Inc. |
| Ispravka | ISI/Web of Science Elečas Rang časopisa Citati: ISI/Web of Science |
